CNTA
Centessa Pharmaceuticals Plc
NASDAQ · Healthcare · Biotechnology · GB
$40.50
+0.00%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-51.4%
Return on equity
-39.1%
Return on assets
-51.9%
Return on invested capital
0.00x
Asset turnover
-$208.8M
Cash from operations
$1.79
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026